BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 19481958)

  • 1. Lifetime prevalence of comorbid mood disorders in a representative sample of Canadians with type 1 diabetes.
    Fuller-Thomson E; Milinovich JL; Merighi JR
    J Diabetes Complications; 2010; 24(5):297-300. PubMed ID: 19481958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lifetime prevalence of suicidal ideation in a representative sample of Canadians with type 1 diabetes.
    Fuller-Thomson E; Sawyer JL
    Diabetes Res Clin Pract; 2009 Jan; 83(1):e9-11. PubMed ID: 19070912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of mood and anxiety disorders in Australian women.
    Williams L; Jacka F; Pasco J; Henry M; Dodd S; Nicholson G; Kotowicz M; Berk M
    Australas Psychiatry; 2010 Jun; 18(3):250-5. PubMed ID: 20482429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of psychiatric disorders in an onset cohort of adults with type 1 diabetes.
    Petrak F; Hardt J; Wittchen HU; Kulzer B; Hirsch A; Hentzelt F; Borck K; Jacobi F; Egle UT; Hoffmann SO
    Diabetes Metab Res Rev; 2003; 19(3):216-22. PubMed ID: 12789655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Affective and anxiety disorders in a German sample of diabetic patients: prevalence, comorbidity and risk factors.
    Hermanns N; Kulzer B; Krichbaum M; Kubiak T; Haak T
    Diabet Med; 2005 Mar; 22(3):293-300. PubMed ID: 15717877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nationwide survey to compare the prevalence of transient elevation of liver transaminase during treatment of diabetic ketosis or ketoacidosis in new-onset acute and fulminant type 1 diabetes mellitus.
    Takaike H; Uchigata Y; Iwamoto Y; Imagawa A; Iwahashi H; Kanatsuka A; Kawasaki E; Kobayashi T; Shimada A; Shimizu I; Maruyama T; Hanafusa T; Makino H
    Ann Med; 2008; 40(5):395-400. PubMed ID: 18484350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes in Asian communities.
    Carlisle D
    Nurs Times; 1997 Sep 17-23; 93(38):52-4, 56. PubMed ID: 9362909
    [No Abstract]   [Full Text] [Related]  

  • 8. [Childhood obesity as a risk factor for diabetes mellitus type I: the accelerator hypothesis].
    Swinnen SM; Gillis P; Massa GG
    Ned Tijdschr Geneeskd; 2007 Jan; 151(2):134-7. PubMed ID: 17315492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of an increasing prevalence of diagnosed diabetes mellitus in the Poole area from 1983 to 1996.
    Gatling W; Budd S; Walters D; Mullee MA; Goddard JR; Hill RD
    Diabet Med; 1998 Dec; 15(12):1015-21. PubMed ID: 9868974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comorbidity of diabetes mellitus and eating disorders. A comparison of psychological features of eating disordered and non-eating disordered patients with diabetes mellitus].
    Herpertz S; Albus C; Lohff S; Michalski K; Masrour M; Lichtblau K; Köhle K; Mann K; Senf W
    Psychother Psychosom Med Psychol; 2000; 50(3-4):161-8. PubMed ID: 10780157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of mood and anxiety disorders in the community: results from the Israel National Health Survey.
    Levinson D; Zilber N; Lerner Y; Grinshpoon A; Levav I
    Isr J Psychiatry Relat Sci; 2007; 44(2):94-103. PubMed ID: 18080646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survey on acute and chronic complications in children and adolescents with type 1 diabetes at Muhimbili National Hospital in Dar es Salaam, Tanzania.
    Majaliwa ES; Munubhi E; Ramaiya K; Mpembeni R; Sanyiwa A; Mohn A; Chiarelli F
    Diabetes Care; 2007 Sep; 30(9):2187-92. PubMed ID: 17563337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-medication of mood disorders with alcohol and drugs in the National Epidemiologic Survey on Alcohol and Related Conditions.
    Bolton JM; Robinson J; Sareen J
    J Affect Disord; 2009 Jun; 115(3):367-75. PubMed ID: 19004504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of mood, anxiety, and substance-abuse disorders for older Americans in the national comorbidity survey-replication.
    Gum AM; King-Kallimanis B; Kohn R
    Am J Geriatr Psychiatry; 2009 Sep; 17(9):769-81. PubMed ID: 19700949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Considering comorbidity in social phobia.
    Chartier MJ; Walker JR; Stein MB
    Soc Psychiatry Psychiatr Epidemiol; 2003 Dec; 38(12):728-34. PubMed ID: 14689178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic obstructive lung diseases and prevalence of mood, anxiety, and substance-use disorders in a large population sample.
    Patten SB; Williams JV
    Psychosomatics; 2007; 48(6):496-501. PubMed ID: 18071096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and costs of diabetes treated with insulin in France.
    Detournay B; Raccah D; Cadilhac M; Eschwège E
    Diabetes Metab; 2005 Jun; 31(3 Pt 2):3-18. PubMed ID: 16142041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advance directives for insulin-using diabetic patients.
    Toth EL; Gill S; Godkin D; Lee KC
    CMAJ; 1998 May; 158(9):1130-1. PubMed ID: 9597959
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.